首页 › 基金 › DELTEC ASSET MANAGEMENT LLC › OCUL
DELTEC ASSET MANAGEMENT LLC 对 OCUL 的持仓历史
OCULAR THERAPEUTIX INC · 医疗保健
DELTEC ASSET MANAGEMENT LLC 在 Q3 2026 的 13F 申报中披露持有 OCUL(OCULAR THERAPEUTIX INC)2,623,597 股,市值约 US$20.1M,约占其申报组合的 3.17%,在其申报持仓中市值排名第 7 位。 DELTEC ASSET MANAGEMENT LLC 最近 13 个申报季度中有 13 个季度披露了 OCUL 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
DELTEC ASSET MANAGEMENT LLC 对 OCUL 的持仓演变
DELTEC ASSET MANAGEMENT LLC 于 Q3 2023 首次披露 OCUL 持仓:2,061,797 股(约 US$6.5M)。 该持仓在 Q3 2025 达到峰值 2,762,459 股,市值约 US$32.3M。 在 13 次申报中,DELTEC ASSET MANAGEMENT LLC 7 次增持、4 次减持、1 次保持不变。 最近一期申报(Q3 2026)显示持股 2,623,597 股、市值约 US$20.1M,环比增持 147,400 股。。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 2.06M | $6.47M | 新进 |
| Q4 2023 | 2.44M | $10.90M | 增持 |
| Q1 2024 | 2.36M | $21.51M | 减持 |
| Q2 2024 | 2.59M | $17.72M | 增持 |
| Q3 2024 | 2.60M | $22.62M | 持有 |
| Q4 2024 | 2.62M | $22.34M | 增持 |
| Q1 2025 | 2.72M | $19.91M | 增持 |
| Q2 2025 | 2.79M | $25.94M | 增持 |
| Q3 2025 | 2.76M | $32.29M | 减持 |
| Q4 2025 | 2.49M | $30.20M | 减持 |
| Q1 2026 | 2.34M | $19.83M | 减持 |
| Q2 2026 | 2.48M | $24.32M | 增持 |
| Q3 2026 | 2.62M | $20.12M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 OCUL 与 13F 数据
OCUL(OCULAR THERAPEUTIX INC)属于医疗保健行业。我们追踪的基金中还有 37 只申报持有 OCUL,申报仓位最大的包括:Deep Track Capital, LP (US$193.3M), Avoro Capital Advisors LLC (US$123.1M), Venrock Adviser, LLC (US$101.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 OCUL 的基金
- Deep Track Capital, LP 19.69M 股 · $193.32M · Q2 2026
- Avoro Capital Advisors LLC 12.54M 股 · $123.14M · Q2 2026
- Venrock Adviser, LLC 10.35M 股 · $101.61M · Q2 2026
- SUMMER ROAD LLC 12.46M 股 · $95.59M · Q3 2026
- Logos Global Management LP 5.30M 股 · $52.05M · Q2 2026
- Octagon Capital Advisors LP 2.08M 股 · $20.38M · Q2 2026
- TCG Crossover Management, LLC 1.65M 股 · $16.18M · Q2 2026
- Defilade Capital Management, L.P. 1.49M 股 · $14.63M · Q2 2026
- Boxer Capital Management, LLC 1.30M 股 · $12.77M · Q2 2026
- Knoll Capital Management, LLC 1.15M 股 · $11.30M · Q2 2026
更多关于 DELTEC ASSET MANAGEMENT LLC
常见问题
How long has DELTEC ASSET MANAGEMENT LLC held OCUL?
DELTEC ASSET MANAGEMENT LLC has disclosed OCUL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is DELTEC ASSET MANAGEMENT LLC's current position in OCUL?
As of Q3 2026, DELTEC ASSET MANAGEMENT LLC holds 2.62M shares of OCUL (OCULAR THERAPEUTIX INC), valued at $20.12M, representing 3.17% of its reported portfolio and ranking #7.
Has DELTEC ASSET MANAGEMENT LLC been buying or selling OCUL?
In the latest 13F filing (Q3 2026), DELTEC ASSET MANAGEMENT LLC increased its position in OCUL. The position peaked in Q3 2025 at 2.76M shares.
Which other funds hold OCUL?
Other major institutional holders of OCUL include Deep Track Capital, LP, Avoro Capital Advisors LLC, Venrock Adviser, LLC, among 37 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.